Regulation

Is Trump's Cannabis Shift a Cure or a Public Health Risk?
Care Is Trump's Cannabis Shift a Cure or a Public Health Risk?

We're joined today by Faisal Zain, a leading expert in health policy, to dissect the recent executive order directing the reclassification of marijuana. This landmark decision has sent shockwaves through the political and medical establishments, and we'll be exploring the intricate

Are You Ready for Medicare's 2026 Overhaul?
Technology Are You Ready for Medicare's 2026 Overhaul?

Beyond the Headlines: A Fundamental Shift in Healthcare is Underway The familiar landscape of healthcare reimbursement and operations is about to undergo a seismic shift, fundamentally altering the financial and procedural ground beneath every medical practice in the nation. The 2026 Medicare

Is Colombia's Healthcare System Doomed to Fail?
Public Policy Is Colombia's Healthcare System Doomed to Fail?

The collapse of a landmark legislative effort to reshape a nation's health has left Colombia's medical system suspended over a precipice, with millions of citizens caught in the precarious balance between a broken present and an unwritten future. The recent congressional defeat of

GSK Gets FDA Approval for Twice-Yearly Asthma Drug
Care GSK Gets FDA Approval for Twice-Yearly Asthma Drug

With the recent FDA approval of Exdensur, a groundbreaking severe asthma treatment from GSK, the landscape for respiratory biologics is set for a significant shift. To unpack what this means for patients, physicians, and the market, we are joined by Faisal Zain, a healthcare expert with deep

Automation Drives a Smarter Healthcare System
Technology Automation Drives a Smarter Healthcare System

The modern healthcare landscape is defined not by the breakthrough treatments it offers but by the monumental challenge of managing the overwhelming surge of information that makes them possible. As medical facilities navigate an ever-expanding universe of data, the reliance on outdated, manual

Healthcare M&A Poised for a Major Rebound in 2026
Business Healthcare M&A Poised for a Major Rebound in 2026

After a year defined more by cautious observation than by headline-grabbing transactions, the undercurrents of strategic realignment and technological disruption are now set to propel healthcare M&A into a period of dramatic resurgence. The market has spent months recalibrating expectations and

Loading

Subscribe to our weekly news digest

Keep up to date with the latest news and events

Paperplanes Paperplanes Paperplanes
Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later